Dr Paolo Muraro

  • NHS Base
    Imperial College Healthcare NHS Trust
  • Speciality
    Neurology
  • Sub speciality
    Multiple Sclerosis
  • Consulting address
    Harley Street at University College Hospital, 5th Floor, Macmillan Cancer Centre, Huntley Street, London, WC1E 6AG
  • Research interests
    Multiple Sclerosis, Neuroimmunology
  • Languages
    English
  • Biography

    Dr Muraro graduated from University of Rome “La Sapienza” and went on to train in Clinical Neurology and Neuroimmunology in Italy and the United States, where he has been a Senior Research Fellow at the Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, as well as a Neurologist at the Clinical Centre, National Institutes of Health, Bethesda, MD, USA.

    He is a Clinical Reader in Neuroimmunology and heads the Clinical Neuroimmunology Group at the Centre for Neuroscience in the Division of Brain Sciences, Department of Medicine, Imperial College London. He is also an Honorary Consultant Neurologist at Imperial College Healthcare NHS Trust.

    Dr Muraro is a Member of the UK Multiple Sclerosis Society Research Strategy Working Group and of the Scientific Committee of the Italian Multiple Sclerosis Foundation (FISM), and Chair of the Autoimmune Disease Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR; the largest organization of hematopoietic cell transplantation and cellular therapy research worldwide), University of Wisconsin, USA.

    He is member of the Faculty of the European School of Neuroimmunology (ESNI) and of the Faculty of 1000 (f1000) Medicine, and has often been invited to present as Speaker to plenary sessions at international scientific meetings in the fields of MS, Neuroimmunology and bone marrow transplantation.

    His research programme is aimed at understanding and developing effective therapies for inflammatory neurological diseases, particularly multiple sclerosis (MS). His scientific contributions include studies of T cell repertoires in health and autoimmune disorders, and the elucidation of the mechanisms of action of immuno-modulatory treatments and haematopoietic stem cell transplantation (HSCT) in MS. He has published more than 60 peer-reviewed articles in international scientific journals in addition to a number of book chapters, editorial comments and interviews. His research programme is funded by the Medical Research Council, the UK Multiple Sclerosis Society, the UK Stem Cell Foundation, the Wellcome Trust, and the Italian Multiple Sclerosis Society.

    He has received the 2013 <span style=”font-style: inherit; font-weight: inherit;”>Van Bekkum Award, the most prestigious</span> European Blood and Marrow Transplantation (EBMT) award for the best abstract submitted to the physician’s programme.